![Charles Magness](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Magness
Direttore/Membro del Consiglio presso Kineta One LLC
Patrimonio netto: 329 439 $ in data 30/06/2024
Provenienza dei contatti di primo grado di Charles Magness
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Illumigen Biosciences, Inc.
![]() Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Charles Magness tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Kineta Chronic Pain LLC
![]() Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Kineta Chronic Pain LLC operates as a biotechnology company. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense systems. The company was founded in 2011 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree | |
CBI CO., LTD. | Auto Parts: OEM | Director/Board Member | |
Kineta, Inc. (Washington)
![]() Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Founder | |
Kineta Immuno-Oncology LLC
![]() Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Kineta Immuno-Oncology LLC operates as a biotech company. It specializes in RIG-I pathway, tumor immunity, publications and posters. The company was founded in 2016 and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer | |
Kineta Viral Hemorrhagic Fever LLC
![]() Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Kv1.3 Therapeutics, Inc.
![]() Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
KINETA, INC. | Pharmaceuticals: Major | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Corea del Sud | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Producer Manufacturing | 2 |
Posizioni
Director/Board Member | 7 |
Chief Tech/Sci/R&D Officer | 3 |
Founder | 3 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 1 |
Contatti più connessi
Insiders | |
---|---|
Shawn Iadonato | 11 |
- Borsa valori
- Insiders
- Charles Magness
- Connessioni Società